amikacin kabi 5 mg/ml raztopina za infundiranje
amikacin - raztopina za infundiranje - amikacin 5 mg / 1 ml - amikacin
amikacin kabi 5 mg/ml raztopina za infundiranje
amikacin - raztopina za infundiranje - amikacin 5 mg / 1 ml - amikacin
amikacin kabi 5 mg/ml raztopina za infundiranje
amikacin - raztopina za infundiranje - amikacin 5 mg / 1 ml - amikacin
sivextro
merck sharp & dohme b.v. - tedizolidolidov fosfat - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibacterials za sistemsko uporabo, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.
rydapt
novartis europharm ltd - midostaurin - leukemia, myeloid, acute; mastocytosis - antineoplastična sredstva - rydapt je navedeno:v kombinaciji s standardno daunorubicin in cytarabine indukcije in visok odmerek cytarabine konsolidacije kemoterapijo, in za bolnike v popolni odgovor sledi rydapt en agent za vzdrževanje terapija, pri odraslih bolnikih, ki so na novo zboleli za akutno mieloično levkemijo (aml), ki so flt3 mutacije pozitivna (glej poglavje 4. 2);kot monotherapy za zdravljenje odraslih bolnikov z agresivno sistemske mastocytosis (asm), sistemsko mastocytosis s povezanimi hematoloških neoplasm (sm ahn), ali jambor celice levkemijo (mcl).
aservo equihaler
boehringer ingelheim vetmedica gmbh - ciclesonide - dihalni sistem, druga zdravila za obstruktivne pljučne bolezni, inhalants - konji - za lajšanje kliničnih znakov hude konjskega astme (prej znan kot periodično obstrukcijo dihalnih poti – (rao), poletno pašo povezane periodično obstrukcijo dihalnih poti – (spa-rao)).
moloxin 400 mg filmsko obložene tablete
krka, d.d., novo mesto - moksifloksacin - filmsko obložena tableta - moksifloksacin 400 mg / 1 tableta - moksifloksacin
moloxin 400 mg filmsko obložene tablete
krka, d.d., novo mesto - moksifloksacin - filmsko obložena tableta - moksifloksacin 400 mg / 1 tableta - moksifloksacin
moloxin 400 mg/250 ml raztopina za infundiranje
krka, d.d., novo mesto - moksifloksacin - raztopina za infundiranje - moksifloksacin 1,6 mg / 1 ml - moksifloksacin